SEIZE THE $50 BILLION SITE-OF-CARE SHIFT OPPORTUNITY
Get the tools, data, and insights to drive growth.
Learn more
RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Around the nation: California to mandate Covid-19 vaccine for eligible students


California Gov. Gavin Newsom announced that the state will mandate Covid-19 vaccines for all eligible public and private school students, in today's bite-sized hospital and health industry news from California, District of Columbia, and Texas.

  • California: California Gov. Gavin Newsom (D) on Friday announced plans to issue a Covid-19 vaccine mandate for all eligible students—a requirement that will likely take effect next school year. The Covid-19 vaccine will be added to California's existing list of required vaccines for public schools. The mandate will apply only to students 16 or older at first but will likely extend to 12- to 15-year-olds upon FDA approval for this age group. (Garfinkel, Axios, 10/1; Colliver et al., Politico, 10/1)
  • Texas: The University of Texas MD Anderson Cancer Center in Houston named Caroline Chung VP and chief data officer, effective Oct. 1. Chung joined the organization in 2016 to direct the MR Program in Radiation Oncology. According to David Jaffray, SVP and chief technology and digital officer of MD Anderson, "We have established the role of [chief data officer] to develop our data strategy and manage one of our most valuable strategic assets—our data." He added, "As a practicing radiation oncologist, researcher and educator, Dr. Chung already has advanced MD Anderson's thinking on data governance and initiated new approaches that have set an exciting path for our future. Her extensive experience leading data-driven operations and innovations makes her uniquely qualified for this role." (Jensik, Becker's Hospital Review, 9/30)
  • District of Columbia: The Health Resources and Services Administration (HRSA) on Thursday formally rescinded a rule targeting community health centers that would have required them to pass discounts for insulin and Epi-Pens from the 340B Drug Pricing Program directly to patients. According to an HRSA notice, the regulation is being pulled because of the "excessive administrative costs and burdens that implementation would have imposed on health centers." (Hellmann, Modern Healthcare, 9/30)

SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.